Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.830
-0.030 (-1.05%)
At close: Mar 13, 2026, 4:00 PM EDT
2.940
+0.110 (3.89%)
After-hours: Mar 13, 2026, 6:51 PM EDT

Anixa Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
94.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Oct 31, 2025---
Oct 31, 2024---
Oct 31, 2023210.00K--
Oct 31, 2022---
Oct 31, 2021512.00K--
Oct 31, 2020---
Oct 31, 2019250.00K-862.50K-77.53%
Oct 31, 20181.11M750.00K206.90%
Oct 31, 2017362.50K62.50K20.83%
Oct 31, 2016300.00K-8.96M-96.76%
Oct 31, 20159.26M5.59M152.36%
Oct 31, 20143.67M3.28M843.12%
Oct 31, 2013388.85K-551.16K-58.63%
Oct 31, 2012940.01K-63.18K-6.30%
Oct 31, 20111.00M272.52K37.30%
Oct 31, 2010730.68K-325.12K-30.79%
Oct 31, 20091.06M-1.01M-48.83%
Oct 31, 20082.06M1.58M323.77%
Oct 31, 2007486.85K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortress Biotech62.30M
Q32 Bio53.74M
Gossamer Bio44.05M
Coya Therapeutics3.99M
Pyxis Oncology2.82M
Genelux8.00K
Revenue Rankings